ArticleCancer immunology, immunotherapy : CII2023

Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages.

Femke A I Ehlers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.